Olivier Terrier

Citado por

	Total	Desde 2019
Citas	4662	3988
Índice h	36	30
Índice i10	57	54

1100

550

275

825

2011201220132014201520162017201820192020202120222023202422 20 47 70 104 118 127 142 175 385 796 1073 902 639

Acceso público

Ver todo

53 artículos

2 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Andrés PizzornoCentre International de Recherche en Infectiologie (CIRI) - Team VirPath, Lyon, FranceDirección de correo verificada de univ-lyon1.fr
Guy BoivinCHU de Québec and Laval UniversityDirección de correo verificada de crchudequebec.ulaval.ca
jean-christophe bourdonDirector of Research, University of Dundee, UKDirección de correo verificada de dundee.ac.uk
Julien TextorisbioMérieuxDirección de correo verificada de biomerieux.com
Jeremie GuedjResearcher at the French Institute of Health and Medical Research (INSERM)Dirección de correo verificada de inserm.fr
samuel constantCEODirección de correo verificada de epithelix.com
David P LaneA*STARDirección de correo verificada de p53lab.a-star.edu.sg
Pr France MentrePr of Biostatistics, University Paris DiderotDirección de correo verificada de inserm.fr
Alan S PerelsonSenior Fellow, Los Alamos National LaboratoryDirección de correo verificada de lanl.gov
Emmanuelle CometsINSERM (National Institute of Health and Medical Research, France)Dirección de correo verificada de inserm.fr
roland marquetCNRS, UPR 9002Dirección de correo verificada de ibmc-cnrs.unistra.fr
Romain MarlinCenter for Immunology of Viral Infections and Autoimmune diseases (ImVA), Université Paris-SudDirección de correo verificada de cea.fr
Franck TouretUnité des virus émérgentsDirección de correo verificada de univ-amu.fr
Glaucia Paranhos-BaccalabioMérieux SADirección de correo verificada de biomerieux.com
Jonathan HoffmannDirección de correo verificada de fmx-international.org
Alexandre GaymardDirección de correo verificada de chu-lyon.fr
emmanuel giudiceMaître de Conférences, UMR CNRS 6290, University of Rennes 1Dirección de correo verificada de univ-rennes1.fr
Guy SchoehnGroup Leader in Electron MicroscopeDirección de correo verificada de ibs.fr
Bruno FèveProfesssuer de médecine, Sorbonne UniversitéDirección de correo verificada de inserm.fr
francis berenbaumDirección de correo verificada de sat.aphp.fr

Seguir

Olivier Terrier

VirPath Team, Centre international de Recherche en Infectiologie (CIRI), INSERM U1111 UMR CNRS 5308

Dirección de correo verificada de univ-lyon1.fr

Influenza viruses Virus-Host interactions


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021	513	2021
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates P Maisonnasse, J Guedj, V Contreras, S Behillil, C Solas, R Marlin, ... Nature 585 (7826), 584-587, 2020	396	2020
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021	372	2021
Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia A Pizzorno, B Padey, T Julien, S Trouillet-Assant, A Traversier, ... Cell Reports Medicine 1 (4), 2020	255	2020
Timing of antiviral treatment initiation is critical to reduce SARS‐CoV‐2 viral load A Gonçalves, J Bertrand, R Ke, E Comets, X De Lamballerie, D Malvy, ... CPT: pharmacometrics & systems pharmacology 9 (9), 509-514, 2020	233	2020
Influenza viruses and mRNA splicing: doing more with less J Dubois, O Terrier, M Rosa-Calatrava MBio 5 (3), 10.1128/mbio. 00070-14, 2014	175	2014
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022	155	2022
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2 A Pizzorno, B Padey, J Dubois, T Julien, A Traversier, V Dulière, P Brun, ... Antiviral research 181, 104878, 2020	148	2020
Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses B Essere, M Yver, C Gavazzi, O Terrier, C Isel, E Fournier, F Giroux, ... Proceedings of the National Academy of Sciences 110 (40), E3840-E3848, 2013	132	2013
Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy A Pizzorno, B Padey, O Terrier, M Rosa-Calatrava Frontiers in immunology 10, 531, 2019	123	2019
Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3 D Thuringer, G Jego, G Wettstein, O Terrier, L Cronier, N Yousfi, ... The FASEB Journal 27 (10), 4169-4183, 2013	122	2013
Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response V Marcel, K Fernandes, O Terrier, DP Lane, JC Bourdon Cell Death & Differentiation 21 (9), 1377-1387, 2014	110	2014
Cold oxygen plasma technology efficiency against different airborne respiratory viruses O Terrier, B Essere, M Yver, M Barthélémy, M Bouscambert-Duchamp, ... Journal of Clinical Virology 45 (2), 119-124, 2009	104	2009
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021	91	2021
Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a O Terrier, J Textoris, C Carron, V Marcel, JC Bourdon, M Rosa-Calatrava Journal of General Virology 94 (5), 985-995, 2013	90	2013
Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release S Eymieux, Y Rouillé, O Terrier, K Seron, E Blanchard, M Rosa-Calatrava, ... Cellular and Molecular Life Sciences 78, 3565-3576, 2021	82	2021
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia D Asarnow, B Wang, WH Lee, Y Hu, CW Huang, B Faust, PML Ng, ... Cell 184 (12), 3192-3204. e16, 2021	71	2021
The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses F Durupt, D Koppers-Lalic, B Balme, L Budel, O Terrier, B Lina, L Thomas, ... Cancer gene therapy 19 (1), 58-68, 2012	71	2012
Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives Q Le Hingrat, B Visseaux, C Laouenan, S Tubiana, L Bouadma, ... Clinical Microbiology and Infection 27 (5), 789. e1-789. e5, 2021	70	2021
Viral and bacterial co-infection in severe pneumonia triggers innate immune responses and specifically enhances IP-10: a translational study J Hoffmann, D Machado, O Terrier, S Pouzol, M Messaoudi, W Basualdo, ... Scientific reports 6 (1), 38532, 2016	60	2016

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores